FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

765663002: Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674142015 Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674143013 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Product containing bumetanide in oral dose form (medicinal product form) false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Potassium chloride-containing product in oral dose form false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 500 false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mcg false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Bumetanide (substance) false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide (substance) false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 573 false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Bumetanide and potassium chloride only product in oral dose form true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Plays role Loop diuretic therapeutic role true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Bumetanide (substance) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide (substance) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has basis of strength substance (attribute) Potassium chloride true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mcg true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start